Clinical Trials Logo

Escherichia Coli Diarrhea clinical trials

View clinical trials related to Escherichia Coli Diarrhea.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04838587 Completed - Clinical trials for Escherichia Coli Diarrhea

An Epidemiological Surveillance Study to Determine the Incidence of ETEC in Children and Infants in Lusaka

ETEC-Surv
Start date: October 15, 2020
Phase:
Study type: Observational

Diarrhoea is the one of the top five leading causes of death among children below the age of five years, globally. It is estimated that one in ten deaths in children under five is attributed to diarrhoea. Enterotoxigenic E.coli (ETEC) is one of the major causative agents of moderate-to-severe (MSD) diarrhoea among children both globally and in Zambia. The overall aim of this study is to document the burden of ETEC associated diarrhoea in Zambian children under 3 years of age.

NCT ID: NCT02531802 Completed - Clinical trials for Escherichia Coli Diarrhea

Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh

ETVAX/dmLT
Start date: October 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if the ETEC vaccine ETVAX with and without dmLT adjuvant is safe and immunogenic in adults, children, toddlers and infants in Bangladesh.